Cytotoxic serum factors in patients with renal cell carcinoma.
D000230:Adenocarcinoma / Q000276:immunology* / Q000473:pathology; D000912:Antibodies, Neoplasm / Q000032:analysis; D000917:Antibody Formation; D000918:Antibody Specificity; D000951:Antigens, Neoplasm; D002471:Cell Transformation, Neoplastic; D003165:Complement System Proteins / Q000032:analysis; D046508:Culture Techniques; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D007106:Immune Sera / Q000032:analysis; D007680:Kidney Neoplasms / Q000276:immunology* / Q000473:pathology; D008213:Lymphocyte Activation
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D007106:Immune Sera; D003165:Complement System Proteins